Scarica l'app Stockscreener
6.90
1.62%
0.11
Dopo l'orario di chiusura:
6.99
0.09
+1.30%
Precedente Chiudi:
$6.79
Aprire:
$6.45
Volume 24 ore:
1.44M
Relative Volume:
1.27
Capitalizzazione di mercato:
$427.28M
Reddito:
$170.16M
Utile/perdita netta:
$-312.76M
Rapporto P/E:
-1.214
EPS:
-5.6837
Flusso di cassa netto:
$-178.72M
1 W Prestazione:
+7.64%
1M Prestazione:
-2.13%
6M Prestazione:
-56.79%
1 anno Prestazione:
+15.77%
Intervallo 1D:
$6.40
$7.11
Intervallo di 1 settimana:
$5.37
$7.11
Portata 52W:
$5.00
$17.58
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Nome
Ginkgo Bioworks Holdings Inc
Settore
Industria
Telefono
(877) 442-5362
Indirizzo
27 DRYDOCK AVENUE, BOSTON
Compare DNA vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
6.90 | 427.28M | 170.16M | -312.76M | -178.72M | -5.6837 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-15 | Downgrade | BTIG Research | Neutral → Sell |
| 2024-05-10 | Downgrade | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-06-02 | Downgrade | Goldman | Neutral → Sell |
| 2023-05-11 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | Iniziato | Berenberg | Buy |
| 2022-10-04 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-03-02 | Ripresa | Cowen | Outperform |
| 2022-02-23 | Iniziato | Goldman | Neutral |
| 2022-02-01 | Iniziato | BofA Securities | Neutral |
| 2022-01-28 | Iniziato | BofA Securities | Buy |
| 2022-01-07 | Iniziato | BTIG Research | Buy |
| 2021-11-29 | Iniziato | Jefferies | Buy |
| 2021-10-13 | Iniziato | Raymond James | Outperform |
| 2021-10-12 | Iniziato | William Blair | Outperform |
| 2021-09-20 | Iniziato | HSBC Securities | Buy |
Mostra tutto
Ginkgo Bioworks Holdings Inc Borsa (DNA) Ultime notizie
(DNA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 earnings call transcript - MSN
Aug Shorts: Why is Ginkgo Bioworks Holdings Inc stock going up2026 Trends & Weekly Top Performers Watchlists - baoquankhu1.vn
Market Leaders: What are Ginkgo Bioworks Holdings Incs recent SEC filings showingInsider Buying & Consistent Income Trade Ideas - baoquankhu1.vn
DNA Stock Price, Quote & Chart | GINKGO BIOWORKS HOLDINGS INC (NYSE:DNA) - ChartMill
Is Ginkgo Bioworks Holdings Inc stock a value trap2026 Spike Watch & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Investment Review: Is Ginkgo Bioworks Holdings Inc a strong candidate for buy and hold2026 Volume Leaders & Verified Swing Trading Watchlists - baoquankhu1.vn
Performance Recap: Is Ginkgo Bioworks Holdings Inc a cyclical or defensive stockPortfolio Return Summary & Entry and Exit Point Strategies - baoquankhu1.vn
Wall Street Zen Downgrades Ginkgo Bioworks (NYSE:DNA) to Sell - MarketBeat
Pullback Watch: Is Ginkgo Bioworks Holdings Inc a strong candidate for buy and holdGold Moves & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Vanguard shows 0% stake in Ginkgo Bioworks (NYSE: DNA) after realignment - Stock Titan
Performance Recap: How volatile is Ginkgo Bioworks Holdings Inc stock2026 Stock Rankings & Weekly High Potential Stock Alerts - baoquankhu1.vn
Ginkgo Bioworks: Shedding Biosecurity And Doubling Down On Autonomy (NYSE:DNA) - seekingalpha.com
(DNA) Risk Channels and Responsive Allocation - Stock Traders Daily
Ginkgo Bioworks Holdings, Inc. (DNA) increases despite market slip: Here's what you need to know - MSN
Ginkgo Bioworks Holdings, Inc. (DNA) stock dips while market gains: Key facts - MSN
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Sinks As Market Gains: Here's Why - MSN
Ginkgo Bioworks Holdings, Inc. (DNA) insider RSU vesting triggers tax share sale - Stock Titan
EBITDA per share of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView
Revenue per share of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - tradingview.com
Cash per share of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView
Book value per share of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView
708 Class A shares notified for sale; prior 972-share sale (DNA) - Stock Titan
Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Pre - GuruFocus
How The Ginkgo Bioworks (DNA) Story Is Shifting As Analysts Revisit Growth And Risk - Yahoo Finance
Ginkgo Bioworks Posts On X "New in @sciam today: Researchers at Ginkgo and @OpenAI showed that an AI model working with an autonomous lab can design and iterate real biology experiments at unprecedented speed. From San Francisco, where GPT-5 - Benzinga
(DNA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Analysts Conflicted on These Healthcare Names: Valneva (VALN), Biogen (BIIB) and Ginkgo Bioworks Holdings (DNA) - The Globe and Mail
Ginkgo Bioworks (NYSE:DNA) Price Target Cut to $5.00 by Analysts at BTIG Research - MarketBeat
Ginkgo Bioworks (DNA): BTIG Analyst Lowers Price Target, Maintai - GuruFocus
Ginkgo Bioworks price target lowered to $5 from $9 at BTIG - TipRanks
BTIG cuts Ginkgo Bioworks stock price target on autonomous lab shift - Investing.com Canada
Ginkgo Bioworks Holdings Inc (DNA) PT Lowered to $5 at BTIG - StreetInsider
DNA (DNA) Form 144 shows director notices to sell 2,200 shares on two dates - Stock Titan
Risk Hedge: Why is Ginkgo Bioworks Holdings Inc stock going up2026 PreEarnings & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
DNA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Macro Review: Can Ginkgo Bioworks Holdings Inc expand into new marketsInsider Buying & High Win Rate Trade Alerts - baoquankhu1.vn
Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It Happen - Sahm
Ginkgo Bioworks (NYSE:DNA) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Ginkgo Bioworks Bets on Autonomous Labs Amid Headwinds - The Globe and Mail
Weekly Recap: Is Ginkgo Bioworks Holdings Inc attractive for institutional investorsWall Street Watch & Momentum Based Trading Signals - baoquankhu1.vn
DNA Earnings History & Surprises | EPS & Revenue Results | GINKGO BIOWORKS HOLDINGS INC (NYSE:DNA) - ChartMill
Ginkgo Bioworks Holdings, Inc. 2025 Q4ResultsEarnings Call Presentation (NYSE:DNA) 2026-03-03 - Seeking Alpha
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 Earnings Call Transcript - Insider Monkey
Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure - AI Insider
Ginkgo Bioworks Launches Ginkgo Cloud Lab to Provide Remote Access for Researchers - marketscreener.com
Ginkgo Bioworks Makes Major Pivot (NYSE:DNA) - Seeking Alpha
Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure – Company Announcement - Financial Times
DNA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Ginkgo Bioworks Holdings Inc Azioni (DNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):